Frisbie Memorial Hospital acquires endoscopic ultrasound technology
April 18, 2018
Endoscopic ultrasound enables more accurate diagnoses of cancers and diseases in the GI tract and adjacent structures without surgery
Frisbie Memorial Hospital has acquired cutting-edge technology to perform endoscopic ultrasound (EUS) procedures to diagnose cancers such as esophageal, gastric, rectal and pancreatic cancers; diagnose diseases of internal organs; locate common bile ducts; and evaluate masses in the lining of the GI tract or in enlarged stomach folds. The EUS technology is less invasive and able to provide more reliable diagnoses.
EUS combines ultrasound technology with endoscopy to gain an internal vantage point for better visualization. While conventional endoscopy only provides a view of the innermost lining of the digestive tract, the addition of ultrasound allows the physician to see beyond that wall to visualize all five layers of the GI tract as well as surrounding tissue and organs.
From a clinical perspective, this means that an abnormality below the surface of the digestive tract wall – such as a suspicious growth that was detected at a prior endoscopy or during a CT-scan or physical exam – can be further evaluated under EUS, helping doctors better understand its nature and prescribe the best treatment option.
Because EUS can be used to visualize other organs outside of the digestive tract, EUS plays an important role in diagnosing diseases of the pancreas, bile duct, liver, spleen and gallbladder as well as assessing a variety of cancers.
According to the American Cancer Society, there are more than 125,000 newly diagnosed cases of gastrointestinal cancer each year in the U.S. with more than 91,000 deaths from these diseases in 2013.
By acquiring the new Olympus EUS system, Frisbie is able to further its commitment to providing premiere care for its patients.